Clin2
NCT05585983Possibly a fitRecruiting

Flu shot in newly diagnosed type 1 diabetes patients

Diabetes Mellitus, Type 1

Part of Hormones & metabolism, Immune system & allergy clinical trials.

This trial checks whether giving a flu vaccine to people who were just diagnosed with type 1 diabetes affects their health and immune response. It may help doctors understand if flu vaccination is safe and useful soon after diagnosis.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
7 years to 17 years
Study type
Interventional

Who can take part

  • You are hospitalized with newly diagnosed type 1 diabetes
  • You (and a parent/legal guardian, if needed) can give written consent
  • You have not already received a flu vaccine during this current flu season
  • You are not having a fever or an active infection that is ongoing or suspected right now
  • You can receive this specific flu vaccine safely (no severe past reaction to flu shots or eggs)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06452654Recruiting· Phase 4
Vaccine to prevent type 1 diabetes in high-risk babies

This study tests whether a vaccine given to very young babies (3–4 months old) can prevent type 1 diabetes. It is designed for babies who have a high genetic risk and a family history of the disease.

Vienna
NCT07614412Not yet recruiting· Phase 2
Shingrix vaccine and GLP-1 drug to preserve pancreas function in new type 1 diabetes

This study tests whether a shingles vaccine (Shingrix) combined with a diabetes medication (a GLP-1 agonist) can help preserve your pancreas's ability to make insulin when you've recently been diagnosed with type 1 diabetes. The goal is to slow down the autoimmune attack on your insulin-producing cells.

Riyadh
NCT06455319Recruiting· Phase 2
Personalized ATG with or without verapamil for new type 1 diabetes

This trial tests a new way to give a medicine called anti-thymocyte globulin (ATG) with or without verapamil, a blood pressure drug. It aims to slow down the loss of insulin-making cells in people newly diagnosed with type 1 diabetes.

Aurora, Colorado
NCT07349017Not yet recruiting· Phase 1
Testing a flu vaccine with adjuvant in adults

This trial tests a new flu vaccine with an ingredient to boost your immune response. It's for adults who haven't had the flu or a flu shot in the past 6 months and are generally healthy.

NCT05108818Recruiting· Phase 4
Study immune responses after an flu shot in healthy adults

This study gives you a flu vaccine and measures how your immune system reacts, including both “blood immunity” and “cell immunity.” It’s for healthy adults and mainly aims to better understand how well flu vaccines work in people without major health issues.

Philadelphia, Pennsylvania
NCT07211152Recruiting· Phase 3
Flu vaccine study for pregnant women

This study tests a flu shot designed for pregnant women to see if it is safe and effective. It may help protect you and your baby from the flu during pregnancy.

Mandaluyong, National Capital Region

Hear when a new Diabetes Mellitus, Type 1 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.